24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting

Table 1 Patient demographics and baseline characteristics

Number of patients	54
Number of eyes	56
Mean age in years at diagnosis (SD, range)	80.9 ± 8.8 (57–96)
Male: Female gender	18: 36
Number of eyes pseudophakic at baseline	23
Right: Left eye	28: 28
Mean EDTRS BCVA at diagnosis (SD, range)	60.5 ± 8.9 (35–70)
Mean CRT at diagnosis in μm (SD, range)	384.6 ± 154.9 (210–1193)

ISSN: 1471-2415